VSY Biotechnology GmbH, Signs Agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. on Intraocular Lens Products
VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplem…
VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplem…
Alsanza GmbH is an innovative company offering a large portfolio of Intraocular lenses, Viscoelastics and Eye Irrigating…
European Patent Office (EPO) has issued the decision of appropriate for patent for world’s first and only intraocular le…
Ophthalmic Equipment Market - Key Players Some of the key players in this market are Alcon (U.S.), Bausch & Lomb (U.S.)…
VSY Biotechnology announces AcrivaUD Trinova Trifocal IOL in European Cataract and Refractive Society Congress (ESCRS) w…
Am 27. April wurden in Berlin die Best of "Business-to-Business" Communication Awards 2016 verliehen. ZEISS ist für das…
In einem Virtual-Reality-Projekt für die Carl Zeiss Meditec AG, einen der führenden Anbieter für Intraokularlinsen (IOL)…
Um künftig die optischen Eigenschaften von Objektiven und Linsen besser charakterisieren zu können, fördert das Land die…
Auf der Jahrestagung der American Academy of Ophthalmology (AAO) 2015 in Las Vegas präsentiert ZEISS Innovationen für kl…
Medical technology company Carl Zeiss Meditec AG closed financial year 2013/2014 with a slight growth in revenue from €…